These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36695948)

  • 1. Updates on HIV and Kidney Disease.
    Cervantes CE; Atta MG
    Curr HIV/AIDS Rep; 2023 Apr; 20(2):100-110. PubMed ID: 36695948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.
    Jotwani V; Atta MG; Estrella MM
    J Am Soc Nephrol; 2017 Nov; 28(11):3142-3154. PubMed ID: 28784698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    Cohen SD; Kopp JB; Kimmel PL
    N Engl J Med; 2017 Dec; 377(24):2363-2374. PubMed ID: 29236630
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV and renal disease: a contemporary review.
    Gameiro J; Jorge S; Lopes JA
    Int J STD AIDS; 2018 Jun; 29(7):714-719. PubMed ID: 29343165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 risk variants and the development of HIV-associated nephropathy.
    Goyal R; Singhal PC
    FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of renal disease in children with HIV infection.
    Jindal AK; Tiewsoh K; Pilania RK
    Infect Dis (Lond); 2018 Jan; 50(1):1-12. PubMed ID: 28885079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood HIV-associated nephropathy: 36 years later.
    Ray PE; Li J; Das JR; Tang P
    Pediatr Nephrol; 2021 Aug; 36(8):2189-2201. PubMed ID: 33044676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
    Kopp JB; Heymann J; Winkler CA
    Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.
    Fine DM; Wasser WG; Estrella MM; Atta MG; Kuperman M; Shemer R; Rajasekaran A; Tzur S; Racusen LC; Skorecki K
    J Am Soc Nephrol; 2012 Feb; 23(2):343-50. PubMed ID: 22135313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV at 40: kidney disease in HIV treatment, prevention, and cure.
    Lucas A; Wyatt CM
    Kidney Int; 2022 Oct; 102(4):740-749. PubMed ID: 35850290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney disease in HIV-infected patient].
    Matuszkiewicz-Rowińska J; Wieliczko M
    Wiad Lek; 2016; 69(5):725-728. PubMed ID: 28033595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host factors predisposing to kidney disease in people with HIV.
    Hung RKY; Winkler CA; Post FA
    Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
    Waziri B; Raji YE; Ekrikpo UE; Naicker S
    J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
    Aliyu MH; Wudil UJ; Ingles DJ; Shepherd BE; Gong W; Musa BM; Muhammad H; Sani MU; Abdu A; Nalado AM; Atanda A; Ahonkhai AA; Ikizler TA; Winkler CA; Kopp JB; Kimmel PL; Wester CW
    Trials; 2019 Jun; 20(1):341. PubMed ID: 31182139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1 variants may induce HIV-associated nephropathy during HIV primary infection.
    De Laroche M; Desbuissons G; Rouvier P; Barin F; Deray G; Caumes E; Katlama C; Tubiana R; Isnard Bagnis C
    J Antimicrob Chemother; 2017 May; 72(5):1539-1541. PubMed ID: 28100445
    [No Abstract]   [Full Text] [Related]  

  • 18. APOL1 and kidney disease.
    Pollak MR; Genovese G; Friedman DJ
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.
    Wyatt CM; Klotman PE
    Expert Opin Drug Saf; 2006 Mar; 5(2):275-87. PubMed ID: 16503748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
    Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
    PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.